Abstract: A composite material for preparing a duplex-winding coupling indictor, in mass percentage, is composed of: 70% to 75% of iron-nickel-molybdenum powders, 20% to 25% of amorphous powders, 2% to 5% of epoxy resin, 0.3% to 0.5% of coupling agent, and 0.1% to 1.5% of zinc stearate accordingly, a composite material for preparing a duplex-winding coupling indictor is provided.

Abstract: The present application relates to a regulator containing a tricyclic derivative, a preparation method therefor and an application thereof, and in particular to a compound represented by general formula (Ia), a preparation method therefor and a pharmaceutical composition containing the compound, and an application thereof in the preparation of drugs for preventing and/or treating central nervous system diseases and/or peripheral diseases related to mammalian 5-hydroxytryptamine and/or dopamine and/or norepinephrine neurotransmitter transmission.

Abstract: The present invention relates to compounds that are modulators of Integrin Linked Kinase (ILK), and methods of treating diseases with such compounds. In certain embodiments, the compounds are within Formulas I-VII (e.g., Csbl-1). In some embodiments, the compounds are used to treat an ILK-mediated disease, such as cancer (e.g., triple negative breast cancer) or an inflammatory disease.

Abstract: A process of manufacturing inductor includes preparing coil, using a composite material to prepare a T-core and a U-core, disposing the coil in the cavity of the U-core with the extensions disposed externally of the cavity, inserting the projection through the coil with the cavity being covered by the platform, bending the extensions, heating the assembled U-core, the coil, and the T-core to form a half-finished product, baking the half-finished product, painting and peeling the baked half-finished product, and surface treating the peeled half-finished product by electroplating a composite layer on exposed surfaces of the extensions to obtain an inductor. The composite layer includes, from inside to outside, a copper layer, a nickel layer, and a tin layer.

Abstract: Methods and systems are described for providing hierarchical demand forecasting for state space reduction. Using a hierarchical architecture, a base model may be trained to capture a range of shared structure in a first data set that can be used to draw inferences on using smaller sets of data representative of the “whole picture.” For example, training data may be sampled and prepared and used to train a base model in a first stage. In a next stage, one or more downstream models may be trained on the structure and samples of uncensored demand generated by the base model to produce forecasts for items and locations, including items and locations for which there may be little or no historical data. The downstream models that would otherwise require a large amount of data for training can be generated on demand using less training data, training time, computing processing, and memory.

Abstract: A computer implemented method for creating a prioritized global conversation thread in a data processing system comprising a processing device and a memory comprising instructions which are executed by the processing device, the method can comprise receiving a plurality of messages from a plurality of message channels; combining a plurality of subsets of the plurality of messages to form a plurality of conversation threads, wherein each subset of the plurality of messages forms one of a plurality of the plurality of conversation threads; extracting a plurality of important messages from the plurality of conversation threads, wherein at least one important message of the plurality of important messages is extracted from each of the plurality of conversation threads; storing the plurality of important messages; determining, for each of the plurality of important messages, a message priority; and displaying, to a user, the plurality of important messages based on the message priority.

Abstract: A computer implemented method for creating a prioritized global conversation thread in a data processing system comprising a processing device and a memory comprising instructions which are executed by the processing device, the method can comprise receiving a plurality of messages from a plurality of message channels; combining a plurality of subsets of the plurality of messages to form a plurality of conversation threads, wherein each subset of the plurality of messages forms one of a plurality of the plurality of conversation threads; extracting a plurality of important messages from the plurality of conversation threads, wherein at least one important message of the plurality of important messages is extracted from each of the plurality of conversation threads; storing the plurality of important messages; determining, for each of the plurality of important messages, a message priority; and displaying, to a user, the plurality of important messages based on the message priority.

Abstract: Provided are a spiro-containing derivative, and a preparation method therefor and the use thereof. In particular, provided are a compound as shown in general formula (I), and a preparation method therefor, a pharmaceutical composition containing same, and the use thereof in the preparation of a drug for preventing and/or treating central nervous system diseases related to 5-hydroxytryptamine receptors and/or trace amine-related receptors and/or dopamine receptors in mammals.

Abstract: A method for determining phase locking of critical arc light includes: step 1: monitoring and collecting light radiation intensity of an arc inside a switch cabinet in real time, and converting the collected light radiation intensity into an electrical signal; step 2: extracting a power-frequency fundamental wave of the electrical signal, comparing an amplitude of the power-frequency fundamental wave of the electrical signal with a first threshold, and generating a pre-warning signal based on a comparison result of the first threshold; step 3: comparing the amplitude of the power-frequency fundamental wave of the electrical signal with a second threshold voltage, and generating a control signal based on a comparison result of the second threshold voltage and a protection time threshold; and step 4: protecting the switch cabinet under the critical arc light environment based on the pre-warning signal and the control signal.

Abstract: Disclosed are a motion imaging compensation device and method, relating to imaging technology. The motion imaging compensation device includes a base, an imaging unit, a motion compensation unit and a control system. The base is configured to support the imaging unit, the motion compensation unit and the control system. The motion compensation unit includes a primary rotating structure, a secondary rotating structure and an optical assembly. A rotation shaft of the secondary rotating structure is parallel to that of the primary rotating structure in the three-dimensional space, with an opposite rotating direction. The secondary rotating structure is connected to the optical assembly to drive it to rotate. Rotations of the primary rotating structure and the secondary rotating structure are controlled according to a preset control procedure. The imaging field of view is imaged in a relatively stationary state in a preset motion compensation interval.

Abstract: The present invention relates to a heterocyclic substituted fused ?-carboline derivative, a preparation method therefor, an intermediate thereof and use thereof. The heterocyclic substituted fused ?-carboline derivative has a compound structure as represented by formula (I). Such compound can be used for preparing a medicament for treating neuropsychiatric diseases.

Abstract: The disclosure provides a self-biased magneto-optical non-reciprocal metasurface device. The device includes substrate layer and a sub-wavelength structure layer. The substrate layer is a material layer with a refractive index of 1 to 5 in a microwave frequency band. The sub-wavelength structure layer includes a plurality of square columnar elements arranged in a matrix period with equal period in row and column directions. The square columnar elements include magneto-optical material. The adjustment of phase and amplitude of a circularly polarized electromagnetic wave is achieved by changing the length, width and height of the square columnar elements, and thus the device attains a desired isolation and insertion loss at a center frequency f0. The parameters of the magneto-optical material are: coercivity Hc?1000 A/m; remanence Br?1 kGs; a voigt parameter of a permittivity tensor or permeability tensor in a working frequency band?0.01.

Abstract: A method for determining phase locking of critical arc light includes: step 1: monitoring and collecting light radiation intensity of an arc inside a switch cabinet in real time, and converting the collected light radiation intensity into an electrical signal; step 2: extracting a power-frequency fundamental wave of the electrical signal, comparing an amplitude of the power-frequency fundamental wave of the electrical signal with a first threshold, and generating a pre-warning signal based on a comparison result of the first threshold; step 3: comparing the amplitude of the power-frequency fundamental wave of the electrical signal with a second threshold voltage, and generating a control signal based on a comparison result of the second threshold voltage and a protection time threshold; and step 4: protecting the switch cabinet under the critical arc light environment based on the pre-warning signal and the control signal.

Abstract: The present invention relates to compounds that are modulators of Integrin Linked Kinase (ILK), and methods of treating diseases with such compounds. In certain embodiments, the compounds are within Formulas I-VII (e.g., Csbl-1). In some embodiments, the compounds are used to treat an ILK-mediated disease, such as cancer (e.g., triple negative breast cancer) or an inflammatory disease.

Abstract: The present invention relates to compounds that are modulators of Integrin Linked Kinase (ILK), and methods of treating diseases with such compounds. In certain embodiments, the compounds are within Formulas I-VII (e.g., Csbl-1). In some embodiments, the compounds are used to treat an ILK-mediated disease, such as cancer (e.g., triple negative breast cancer) or an inflammatory disease.

Abstract: The disclosure provides a self-biased magneto-optical non-reciprocal metasurface device. The device includes substrate layer and a sub-wavelength structure layer. The substrate layer is a material layer with a refractive index of 1 to 5 in a microwave frequency band. The sub-wavelength structure layer includes a plurality of square columnar elements arranged in a matrix period with equal period in row and column directions. The square columnar elements include magneto-optical material. The adjustment of phase and amplitude of a circularly polarized electromagnetic wave is achieved by changing the length, width and height of the square columnar elements, and thus the device attains a desired isolation and insertion loss at a center frequency f0. The parameters of the magneto-optical material are: coercivity Hc?1000 A/m; remanence Br?1 kGs; a voigt parameter of a permittivity tensor or permeability tensor in a working frequency band?0.01.

Abstract: A lidar system, including: a laser, an optical detector, a laser antenna, and a silicon-based integrated magneto-optical circulator. The silicon-based integrated magneto-optical circulator includes a silicon-based integrated Mach-Zehnder interference structure or a silicon-based integrated micro-ring structure, and silicon-based integrated magneto-optical waveguides. The silicon-based integrated magneto-optical circulator further includes an input port, a receiving port, and an emission port. The laser is aligned and coupled to the input port of the silicon-based integrated magneto-optical circulator via an optical fiber, a grating coupler, or an edge coupler. The optical detector is aligned and coupled to the receiving port of the silicon-based integrated magneto-optical circulator via the optical fiber, the grating coupler, or the edge coupler.

Abstract: A stepper motor driver with brake drive, a drive device and an automation device are disclosed. The stepper motor driver comprises a microprocessor (1) embedded with a communication protocol, an external interface unit (3) mutually connected to the microprocessor (1) and a communication interface circuit (2); the microprocessor (1) is also connected to a drive control circuit (4) and a brake device (5), and the brake device (5) is mutually connected to the external interface unit (3); the microprocessor (1) is also mutually connected to a power supply circuit (13) that provides a stable power supply voltage. The stepper motor driver has such advantages as simple structure, high capacity to resist interference, high effectiveness, low cost, and ease in maintenance.

Abstract: The application provides a cross-row time delay integral method, apparatus and camera. The method includes obtaining a first stage integral energy in an i-th target region from an i-th row of a first integral piece domain; transferring the first stage integral energy across rows to an i-th row of a second integral piece domain; obtaining the first stage integral energy and an second stage integral energy accumulated in the i-th target region from the i-th row of the second integral piece domain, after an integration period; outputting an image of the i-th target region containing the first stage integral energy and the second stage integral energy. The application performs cross-row integration through the energy obtained by imaging, the shooting of the target can be carried out in a higher-speed environment, the method can be implemented on the existing photoelectric device, and the method has excellent imaging quality and wide applicability.

Abstract: The present invention relates to compounds that are modulators of Integrin Linked Kinase (ILK), and methods of treating diseases with such compounds. In certain embodiments, the compounds are within Formulas I-VII (e.g., Csbl-1). In some embodiments, the compounds are used to treat an ILK-mediated disease, such as cancer (e.g., triple negative breast cancer) or an inflammatory disease.